Literature DB >> 35348999

Effect of catheter ablation on the hemodynamics of the left atrium : Hemodynamics of ablation.

Brennan J Vogl1, Ahmed El Shaer2, Martin Van Zyl2, Ammar M Killu2, Mohamad Alkhouli2, Hoda Hatoum3,4.   

Abstract

BACKGROUND: This study aims to evaluate the impact of catheter ablation for atrial fibrillation (AF) on left atrial (LA) flow dynamics and geometrical changes.
METHODS: This exploratory study included computational flow simulations from 10 patients who underwent catheter ablation for AF. Complete cardiac cycle dataset was simulated before and after ablation using computational fluid dynamics. The study main endpoints were the changes in LA volume, LA velocity, LA wall shear stress (WSS), circulation (Γ), vorticity, pulmonary vein (PV) ostia area, and LA vortices before and after ablation.
RESULTS: There was an average decrease in LA volume (11.58 ± 15.17%) and PV ostia area (16.6 ± 21.41%) after ablation. A non-uniform trend of velocity and WSS changes were observed after ablation. Compared with pre-ablation, 4 patients exhibited lower velocities, WSS distributions, and a decreased Γ (> 8.5%), while 6 developed higher velocities and WSS distributions. These geometrical changes dictated different flow mixing in the LA and distinct vortex patterns, characterized by different spinning velocities, vorticities, and rotational directions. Regions with q-criterion > 0 were found to be dominant in the LA, indicating prevalent rotational vortex structures.
CONCLUSION: Catheter ablation for AF induced different geometrical changes on the LA and the PVs, therefore influencing flow mixing and vortex patterns in the LA, in addition to overall velocity and WSS distribution. Further exploration of the impact of catheter ablation on intracardiac flow dynamics is warranted to discern patterns that may correlate with clinical outcomes.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Hemodynamics; Left atrium

Mesh:

Year:  2022        PMID: 35348999     DOI: 10.1007/s10840-022-01191-3

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.759


  39 in total

Review 1.  Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.

Authors:  Jelena Kornej; Christin S Börschel; Emelia J Benjamin; Renate B Schnabel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

Authors:  Oussama M Wazni; Nassir F Marrouche; David O Martin; Atul Verma; Mandeep Bhargava; Walid Saliba; Dianna Bash; Robert Schweikert; Johannes Brachmann; Jens Gunther; Klaus Gutleben; Ennio Pisano; Dominico Potenza; Raffaele Fanelli; Antonio Raviele; Sakis Themistoclakis; Antonio Rossillo; Aldo Bonso; Andrea Natale
Journal:  JAMA       Date:  2005-06-01       Impact factor: 56.272

3.  Hemodynamic deterioration following radiofrequency ablation of the atrioventricular conduction system.

Authors:  M Vanderheyden; M Goethals; I Anguera; P Nellens; E Andries; J Brugada; P Brugada
Journal:  Pacing Clin Electrophysiol       Date:  1997-10       Impact factor: 1.976

Review 4.  Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review.

Authors:  Jason G Andrade; Oussama M Wazni; Malte Kuniss; Nathaniel M Hawkins; Marc W Deyell; Gian-Battista Chierchia; Steven Nissen; Atul Verma; George A Wells; Ricky D Turgeon
Journal:  J Am Coll Cardiol       Date:  2021-08-31       Impact factor: 24.094

5.  Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.

Authors:  Jens Cosedis Nielsen; Arne Johannessen; Pekka Raatikainen; Gerhard Hindricks; Håkan Walfridsson; Ole Kongstad; Steen Pehrson; Anders Englund; Juha Hartikainen; Leif Spange Mortensen; Peter Steen Hansen
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

6.  Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.

Authors:  Paulus Kirchhof; A John Camm; Andreas Goette; Axel Brandes; Lars Eckardt; Arif Elvan; Thomas Fetsch; Isabelle C van Gelder; Doreen Haase; Laurent M Haegeli; Frank Hamann; Hein Heidbüchel; Gerhard Hindricks; Josef Kautzner; Karl-Heinz Kuck; Lluis Mont; G Andre Ng; Jerzy Rekosz; Norbert Schoen; Ulrich Schotten; Anna Suling; Jens Taggeselle; Sakis Themistoclakis; Eik Vettorazzi; Panos Vardas; Karl Wegscheider; Stephan Willems; Harry J G M Crijns; Günter Breithardt
Journal:  N Engl J Med       Date:  2020-08-29       Impact factor: 91.245

7.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.

Authors:  Carlos A Morillo; Atul Verma; Stuart J Connolly; Karl H Kuck; Girish M Nair; Jean Champagne; Laurence D Sterns; Heather Beresh; Jeffrey S Healey; Andrea Natale
Journal:  JAMA       Date:  2014-02-19       Impact factor: 56.272

8.  Catheter Ablation for Atrial Fibrillation with Heart Failure.

Authors:  Nassir F Marrouche; Johannes Brachmann; Dietrich Andresen; Jürgen Siebels; Lucas Boersma; Luc Jordaens; Béla Merkely; Evgeny Pokushalov; Prashanthan Sanders; Jochen Proff; Heribert Schunkert; Hildegard Christ; Jürgen Vogt; Dietmar Bänsch
Journal:  N Engl J Med       Date:  2018-02-01       Impact factor: 91.245

Review 9.  The vortex--an early predictor of cardiovascular outcome?

Authors:  Gianni Pedrizzetti; Giovanni La Canna; Ottavio Alfieri; Giovanni Tonti
Journal:  Nat Rev Cardiol       Date:  2014-06-03       Impact factor: 32.419

10.  Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.

Authors:  Douglas L Packer; Jonathan P Piccini; Kristi H Monahan; Hussein R Al-Khalidi; Adam P Silverstein; Peter A Noseworthy; Jeanne E Poole; Tristram D Bahnson; Kerry L Lee; Daniel B Mark
Journal:  Circulation       Date:  2021-02-08       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.